NDA 205826 · Dupuy Oxygen
Medical Air, Usp
Medical Air · Inhalation
Last checked: Nov 20, 2026Latest source record: Jul 15, 2013 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2013
Jul 15, 2013
Approved uses
1
Original approval plus efficacy supplements
Registered trials
698
91 Phase 3, 71 recruiting
FAERS reports
18
16 serious, 1 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 20, 2026.
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jul 15, 2013 Original approval · Medical Gas Letter
1 products under this application
- MEDICAL AIR, USP · MEDICAL AIR N/A · GAS, INHALATION · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Medical Air" as an intervention, any sponsor and status, largest first.
- Randomised Evaluation of COVID-19 TherapyPivotal-lookingRecruiting
University of OxfordAcademic, hospital or other
NCT04381936 · 70,000 participants (planned) · Start Mar 19, 2020 · Primary completion Sep 30, 2028
Drug: Lopinavir-Ritonavir; Corticosteroid and 20 more · For: Pneumonia
Sites: Brussels, Belgium; Tallinn, Estonia; Paris, France · 16 sites in all
University of UtahAcademic, hospital or other
NCT07231471 · 10,000 participants (planned) · Start Dec 29, 2025 · Primary completion Jan 1, 2035
Drug: Platelet Rich Plasma Injection · For: Osteoarthritis (OA); Osteoarthritis (OA) of the Knee; Osteoarthritis (OA) of the Hip and 6 more
Sites: Salt Lake City, Utah
The Third Xiangya Hospital of Central South UniversityAcademic, hospital or other
NCT07641387 · 5,000 participants (planned) · Start Apr 1, 2025 · Primary completion Apr 1, 2030
Drug: Environmental exposure · For: Infertility; Infertility Assisted Reproductive Technology; Infertility (IVF Patients)
Sites: Changsha, China
- ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic ShockPivotal-lookingCompleted
The George InstituteAcademic, hospital or other
NCT01448109 · 3,800 participants · Start Jun 13, 2012 · Primary completion Oct 22, 2017
Drug: Hydrocortisone; Sterile air filled vial · For: Septic Shock
Sites: Blacktown, Australia; Camperdown, Australia; Darlinghurst, Australia · 70 sites in all
- Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary BypassPivotal-lookingRecruiting
Xijing HospitalAcademic, hospital or other
NCT06702553 · 3,650 participants (planned) · Start May 19, 2025 · Primary completion Mar 31, 2028
Drug: Nitric Oxide Gas; Standard Care Arm · For: Nitric Oxide; Cardiac Surgery; Cardiopulmonary Bypass and 1 more
Sites: Boston, Massachusetts; Xi'an, China; Tomsk, Russia
Central Hospital, Nancy, FranceAcademic, hospital or other
NCT05916287 · 3,000 participants (planned) · Start Jul 13, 2023 · Primary completion Jul 13, 2027
Drug: Blood and urine samples; 24 hours urinary collection and 1 more · For: Cardiovascular Diseases; Cohort Studies; Genotype and 2 more
Sites: Vandœuvre-lès-Nancy, France
- Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic DiseasePivotal-lookingRecruiting
Rajaie Cardiovascular Medical and Research CenterAcademic, hospital or other
NCT06541691 · 3,000 participants (planned) · Start Mar 6, 2024 · Primary completion Mar 30, 2026
Drug: Enteric-coated aspirin; Plain aspirin · For: Atherosclerotic Cardiovascular Disease; Coronary Artery Disease; Ischemic Heart Disease and 4 more
Sites: Tehran, Iran
- Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary DiseasePivotal-lookingRecruiting
Central Denmark RegionAcademic, hospital or other
NCT05703919 · 1,888 participants (planned) · Start Jun 2, 2025 · Primary completion Feb 29, 2028
Drug: Titrated Oxygen; Standard Oxygen · For: COPD Exacerbation; COPD Exacerbation Acute
Sites: Aarhus N, Denmark
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug interaction3
- atrial fibrillation2
- blood pressure decreased2
- cardiac arrest2
- cyanosis2
- dystonia2
- oxygen saturation decreased2
- polyuria2
- sinus tachycardia2
- acidosis1
- alanine aminotransferase increased1
- anaesthetic complication cardiac1
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2026 | 1 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Impact of exercise training and supplemental oxygen on submaximal exercise performance in patients with COPD.
Neunhäuserer D, Reich B, Mayr B, et al. · Scand J Med Sci Sports 2021 · Randomized Controlled Trial
- Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease.
Neunhäuserer D, Steidle-Kloc E, Weiss G, et al. · Am J Med 2016 · Randomized Controlled Trial
- Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers.
Schröder CF, Basedau H, Moeller M, et al. · Cephalalgia 2023 · Randomized Controlled Trial
- Effects of state anxiety on gait: a 7.5% carbon dioxide challenge study.
Attwood AS, Ludwig CJH, Penton-Voak IS, et al. · Psychol Res 2021 · Randomized Controlled Trial
- Placebo and analgesic nitrous oxide for treatment of the alcohol withdrawal state.
Gillman MA, Lichtigfeld FJ · Br J Psychiatry 1991 · Clinical Trial, Comparative Study
- Nitrous oxide speeds the reduction of distressing intrusive memories in an experimental model of psychological trauma.
Das RK, Tamman A, Nikolova V, et al. · Psychol Med 2016 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Sponsor: Dupuy Oxygen
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.